Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 19,538 shares at $18.92 ($370K) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($370k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.92 | 462 | $9K | 2.4% |
| 2 | $18.92 | 9,538 | $180K | 48.8% |
| 3 | $18.92 | 9,538 | $180K | 48.8% |
| Total | $18.92 avg | 19,538 | $370K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |